In Memoriam

Recently published articles about In Memoriam

JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
In Memoriam

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...
JCP
In Memoriam

October 13, 2020

S. Nassir Ghaemi reflects on the life and accomplishments of this founding pioneer of psychopharmacology.

Recent JCP Articles on In Memoriam

JCP
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
ASCP Corner

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
,
JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
Insights

June 6, 2025

In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...

Recent PCC Articles on In Memoriam

PCC
Efficacy of GLP-1 Agonists in Mental Disorders
Review Article

June 10, 2025

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.
, , , et al
PCC
β-blocker/Colchicine Coingestion With Cocaine Intoxication
Case Report

June 5, 2025

The authors describe a case in which cocaine-induced cardiac toxicity initially masked β-blocker (carvedilol) toxicity and suggest improvements in management for similar cases.
,
PCC
Excited Catatonia in Opioid and Benzodiazepine Withdrawal
Case Report

June 5, 2025

A 37-year-old man developed excited catatonia in the setting of concurrent opioid and benzodiazepine withdrawal, requiring high dosages of benzodiazepines to resolve.
, ,

Featured In Memoriam Research

Physician End-of-Life Preferences Expose Stark Differences
news

June 10, 2025

Research reveals that while most physicians prefer end-of-life comfort over life-extending measures for themselves, their views vary widely.
How Patients Talk May Matter More Than What They Say
news

June 9, 2025

A new study suggests that subtle language cues in how patients talk about their mental health may reveal critical, often overlooked insights.
Restrictive Diets Could Make Depression Worse
news

June 6, 2025

Restrictive diets could make depressive symptoms worse, suggesting that one-size-fits-all eating plans could carry hidden mental health risks.

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe